ARDS Inflammatory Phenotypes Show Differential Mortality and Ventilation Response

ARDS Phenotypes and Ventilation Response

Acute respiratory distress syndrome (ARDS) remains a major challenge in critical care, with high mortality despite advances in lung-protective ventilation [1, 2]. The significant heterogeneity in patient presentation and response to therapies like corticosteroids or prone positioning suggests that ARDS is not a single entity [3, 4]. This variability has fueled efforts to identify distinct biological subtypes, or phenotypes, that could guide more precise management [5]. A recent retrospective analysis provides new data on how two established inflammatory phenotypes, hyperinflammatory and hypoinflammatory, differ in their mortality risk and, critically, in their response to specific mechanical ventilation parameters.

Study Design and Patient Cohorts

To investigate how inflammatory phenotypes influence respiratory mechanics and outcomes, researchers conducted a retrospective cohort study, harmonizing data from two sources. The combined cohort included patients from the multicenter EPVent-2 trial, conducted across 14 hospitals in the USA and Canada, and a large institutional cohort from Beth Israel Deaconess Medical Center. All included patients were adults aged 18 or older with moderate to severe ARDS who were monitored with oesophageal manometry, a technique that allows for more precise measurement of lung stress and strain. After assessing 5778 patients screened between January 2008 and January 2024, a final cohort of 890 patients with complete data was established. Of these, 424 patients (48%) were classified as having the hyperinflammatory phenotype, and 466 patients (52%) were classified as having the hypoinflammatory phenotype.

Differential Mortality and Similar Lung Mechanics

The study's primary outcome, 60-day mortality, revealed a stark contrast between the two groups. A total of 55% of patients (232 of 424) in the hyperinflammatory group died within 60 days, compared to just 29% (136 of 466) in the hypoinflammatory group (p<0.001). After multivariable adjustment, the hyperinflammatory phenotype was associated with a significantly higher mortality risk (adjusted hazard ratio 1.64; 95% CI 1.29-2.09; p<0.001). Paradoxically, this profound difference in survival was not explained by baseline respiratory function. The researchers found that both phenotypes presented with similar lung mechanics, raising the critical question of what drives the excess mortality in the hyperinflammatory subgroup if not the severity of the initial lung injury itself.

Ventilation Parameters and Phenotype-Specific Mortality

Delving deeper into the interplay between ventilation and phenotype, the analysis showed that the mortality impact of certain ventilator settings differed significantly between the groups. While high driving pressure (≥15 cm H2O) was associated with increased mortality in both phenotypes, the effect was substantially more pronounced in the hypoinflammatory group (adjusted hazard ratio 2.01; 95% CI 1.39-2.91) compared to the hyperinflammatory group (aHR 1.46; 95% CI 1.11-1.94), with a statistically significant interaction (pinteraction=0.033). This suggests that patients with the hypoinflammatory phenotype are more susceptible to ventilator-induced lung injury from elevated driving pressures.

A similar pattern emerged for high transpulmonary driving pressure (≥12 cm H2O), a more direct measure of the stress applied to lung tissue. This parameter was strongly associated with mortality in the hypoinflammatory group (aHR 2.36; 95% CI 1.64-3.39) but showed a much weaker, non-significant association in the hyperinflammatory group (aHR 1.18; 95% CI 0.84-1.60), a difference confirmed by a highly significant interaction (pinteraction=0.0010). Furthermore, a potentially protective ventilation target, maintaining end-expiratory transpulmonary pressure within a tight window (±2 cm H2O), was associated with lower mortality in the hypoinflammatory group (aHR 0.66; 95% CI 0.46-0.93) but conferred no such benefit in the hyperinflammatory group (aHR 0.97; 95% CI 0.73-1.27).

Extrapulmonary Organ Failure Drives Hyperinflammatory Mortality

The investigation provides a compelling answer to the question of what drives the higher death rate in the hyperinflammatory group. The analysis revealed that the excess mortality was not primarily a consequence of worsening lung function. Instead, the key driver was extrapulmonary organ failure. A mediation analysis quantified this effect, finding that 46% (95% CI +17 to +79) of the excess mortality in the hyperinflammatory phenotype was mediated by the development of non-pulmonary organ failure. In stark contrast, respiratory failure itself did not mediate the excess mortality (proportion mediated 0%; 95% CI -3 to +4). This finding reframes the hyperinflammatory phenotype as a systemic disease process where the lungs are one of several organs under attack, rather than a condition of isolated pulmonary injury.

Clinical Implications and Future Directions

These findings underscore that the benefits of meticulous lung-protective ventilation may be most pronounced in patients with the hypoinflammatory ARDS phenotype. This group appears more vulnerable to injury from high pressures but also more likely to benefit from precisely targeted ventilator settings. The authors suggest that patients with hypoinflammatory ARDS could be an important population for trial enrichment, a strategy where studies enroll patients most likely to respond to an intervention, thereby increasing the power to detect a treatment effect. However, the researchers explicitly caution that these findings do not support implementing different ventilation strategies based on phenotype in current clinical practice. The study's central message is that while both ARDS phenotypes may present with similar lung mechanics on admission, their prognoses and underlying drivers of mortality are distinct, with systemic organ failure, not respiratory failure, being the primary determinant of the poor outcomes seen in the hyperinflammatory subtype.

References

1. Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine. 2020. doi:10.1001/jamainternmed.2020.0994

2. Network TARDS. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. New England Journal of Medicine. 2000. doi:10.1056/nejm200005043421801

3. Hirano Y, Madokoro S, Kondo Y, Okamoto K, Tanaka H. Corticosteroid treatment for early acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.. Journal of intensive care. 2020. doi:10.1186/s40560-020-00510-y

4. Hu SL, He HL, Pan C, et al. The effect of prone positioning on mortality in patients with acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.. Critical care (London, England). 2014. doi:10.1186/cc13896

5. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky PM, workgroup TA. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care. 2004. doi:10.1186/cc2872